End-of-day quote
Shanghai S.E.
06:00:00 2024-07-16 pm EDT
|
5-day change
|
1st Jan Change
|
9.56
CNY
|
-0.21%
|
|
-0.31%
|
-33.19%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,703
|
3,784
|
3,348
|
3,452
|
3,191
|
2,576
|
Enterprise Value (EV)
1 |
2,461
|
2,525
|
2,265
|
2,356
|
2,152
|
2,415
|
P/E ratio
|
11.9
x
|
12.5
x
|
19.2
x
|
14.9
x
|
11.9
x
|
130
x
|
Yield
|
2.92%
|
2.85%
|
1.61%
|
2.09%
|
3.1%
|
0.35%
|
Capitalization / Revenue
|
2.25
x
|
2.09
x
|
2.15
x
|
1.51
x
|
1.01
x
|
1.32
x
|
EV / Revenue
|
1.49
x
|
1.39
x
|
1.45
x
|
1.03
x
|
0.68
x
|
1.23
x
|
EV / EBITDA
|
4.65
x
|
5.06
x
|
7.22
x
|
5.73
x
|
4.1
x
|
18.2
x
|
EV / FCF
|
14
x
|
49.7
x
|
23.5
x
|
36.7
x
|
-7.21
x
|
-9.17
x
|
FCF Yield
|
7.15%
|
2.01%
|
4.26%
|
2.73%
|
-13.9%
|
-10.9%
|
Price to Book
|
2.1
x
|
1.93
x
|
1.65
x
|
1.57
x
|
1.22
x
|
1.04
x
|
Nbr of stocks (in thousands)
|
180,000
|
180,000
|
180,000
|
180,000
|
180,002
|
180,002
|
Reference price
2 |
20.57
|
21.02
|
18.60
|
19.18
|
17.73
|
14.31
|
Announcement Date
|
4/17/19
|
4/21/20
|
3/23/21
|
4/6/22
|
4/28/23
|
4/24/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,646
|
1,813
|
1,559
|
2,292
|
3,150
|
1,958
|
EBITDA
1 |
529.4
|
499.2
|
313.9
|
411.4
|
524.5
|
132.7
|
EBIT
1 |
482.2
|
447
|
235.8
|
311.5
|
409.1
|
6.409
|
Operating Margin
|
29.29%
|
24.66%
|
15.13%
|
13.59%
|
12.99%
|
0.33%
|
Earnings before Tax (EBT)
1 |
507.5
|
484.9
|
258.4
|
326.4
|
455.1
|
20.09
|
Net income
1 |
312.1
|
303.2
|
174.7
|
232.4
|
315.3
|
20.08
|
Net margin
|
18.96%
|
16.73%
|
11.21%
|
10.14%
|
10.01%
|
1.03%
|
EPS
2 |
1.730
|
1.680
|
0.9700
|
1.290
|
1.490
|
0.1100
|
Free Cash Flow
1 |
175.9
|
50.79
|
96.59
|
64.25
|
-298.4
|
-263.2
|
FCF margin
|
10.69%
|
2.8%
|
6.2%
|
2.8%
|
-9.47%
|
-13.44%
|
FCF Conversion (EBITDA)
|
33.22%
|
10.18%
|
30.77%
|
15.61%
|
-
|
-
|
FCF Conversion (Net income)
|
56.35%
|
16.75%
|
55.28%
|
27.64%
|
-
|
-
|
Dividend per Share
2 |
0.6000
|
0.6000
|
0.3000
|
0.4000
|
0.5500
|
0.0500
|
Announcement Date
|
4/17/19
|
4/21/20
|
3/23/21
|
4/6/22
|
4/28/23
|
4/24/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
1,242
|
1,259
|
1,083
|
1,096
|
1,040
|
161
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
176
|
50.8
|
96.6
|
64.2
|
-298
|
-263
|
ROE (net income / shareholders' equity)
|
20.7%
|
17.1%
|
8.66%
|
10.8%
|
12.9%
|
0.43%
|
ROA (Net income/ Total Assets)
|
13.4%
|
10.5%
|
4.98%
|
5.61%
|
5.56%
|
0.07%
|
Assets
1 |
2,330
|
2,884
|
3,511
|
4,142
|
5,666
|
27,616
|
Book Value Per Share
2 |
9.780
|
10.90
|
11.30
|
12.20
|
14.50
|
13.80
|
Cash Flow per Share
2 |
6.900
|
6.990
|
6.010
|
6.240
|
10.70
|
7.370
|
Capex
1 |
140
|
384
|
215
|
291
|
604
|
661
|
Capex / Sales
|
8.49%
|
21.17%
|
13.8%
|
12.71%
|
19.16%
|
33.78%
|
Announcement Date
|
4/17/19
|
4/21/20
|
3/23/21
|
4/6/22
|
4/28/23
|
4/24/24
|
|
1st Jan change
|
Capi.
|
---|
| -33.19% | 237M | | -13.17% | 3.07B | | -47.13% | 1.42B | | -16.23% | 1.42B | | -19.72% | 1.46B | | -11.30% | 1.18B | | -14.89% | 966M | | +58.87% | 919M | | -35.59% | 850M | | +36.98% | 819M |
Pesticide
|